Corticosteroid therapy is associated with the delay of SARS-CoV-2 clearance in COVID-19 patients

The impact of corticosteroid treatment on virological course of coronavirus disease 2019 (COVID-19) patients remains unclear. This study aimed to explore the association between corticosteroid and viral clearance in COVID-19. The clinical data of COVID-19 patients from 10 hospitals of Jiangsu, China...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of pharmacology 2020-12, Vol.889, p.173556-173556, Article 173556
Hauptverfasser:	Huang, Rui, Zhu, Chuanwu, Jian Wang, Xue, Leyang, Li, Chunyang, Yan, Xiaomin, Huang, Songping, Zhang, Biao, Zhu, Li, Xu, Tianmin, Ming, Fang, Zhao, Yun, Cheng, Juan, Shao, Huaping, Zhao, Xiang-an, Sang, Dawen, Zhao, Haiyan, Guan, Xinying, Chen, Xiaobing, Chen, Yuxin, Wei, Jie, Issa, Rahma, Liu, Longgen, Yan, Xuebing, Wu, Chao
Format:	Artikel
Sprache:	eng
Schlagworte:	Adrenal Cortex Hormones - adverse effects Adult Coronavirus disease 2019 Corticosteroid COVID-19 - virology COVID-19 Drug Treatment Female Full Length Humans Male Methylprednisolone - adverse effects Middle Aged Pandemics Retrospective Studies Risk Factors SARS-CoV-2 - drug effects SARS-CoV-2 - isolation & purification Sex Factors Virus clearance
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!